Ngā hua rapu kaituhi :: APM

1

MicroRNAs: Promising New Antiangiogenic Targets in Cancer mā Sandra Gallach, Silvia Calabuig‐Fariñas, Eloísa Jantus‐Lewintre, Carlos Camps

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win? mā Silvia Calabuig‐Fariñas, Eloísa Jantus‐Lewintre, Alejandro Herreros‐Pomares, Carlos Camps

I whakaputaina 2016

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer mā Anna Valentino, Pablo Reclusa, Rafael Sirera, Marco Giallombardo, Carlos Camps, Patrick Pauwels, Stefania Crispi, Christian Rolfo

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer mā Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

I whakaputaina 2007

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer mā Francesca M. Buffa, Carlos Camps, Laura Winchester, Cameron Snell, Harriet E. Gee, Helen Sheldon, Marian Taylor, Adrian L. Harris, Jiannis Ragoussis

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer mā Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund

I whakaputaina 2010

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer mā Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund

I whakaputaina 2010

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer mā M. Nunez Abad, Silvia Calabuig‐Fariñas, M. Lobo de Mena, Susana Torres, Clara García González, José Ángel García, Vega Iranzo, Carlos Camps

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients mā Rafael Rosell, Kathleen D. Danenberg, V. Alberola, Gerold Bepler, José Javier Sánchez, Carlos Camps, Mariano Provencio, Dolores Isla, Miquel Tarón, Pilar Díz, Á. Artal

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transi... mā Lara Milián, Manuel Mata, Javier Alcácer, María Oliver-Ferrándiz, María Sancho‐Tello, José Javier Martı́n de Llano, Carlos Camps, José M. Galbis, Julián Carretero, Carmen Cardá

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer mā Leonor Puchades‐Carrasco, Eloísa Jantus‐Lewintre, Clara Pérez-Rambla, Francisco García‐García, Rut Lucas-Domínguez, Silvia Calabuig‐Fariñas, Ana Blasco, Joaquı́n Dopazo, Carlos Camps, Antonio Pineda‐Lucena

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations mā Carlos Camps, Nayia Petousi, Celeste Bento, Holger Cario, Richard R. Copley, Mary Frances McMullin, Richard van Wijk, Peter J. Ratcliffe, Peter A. Robbins, Jenny C. Taylor

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations mā Matti Aapro, Ralph V. Boccia, Robert Leonard, Carlos Camps, Mario Campone, Sylvain Choquet, Marco Danova, John A. Glaspy, Iwona Hus, Hartmut Link, Thamer Sliwa, Hans Tesch, Vicente Valero

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Update on systemic treatment in early triple negative breast cancer mā M. Nunez Abad, Silvia Calabuig‐Fariñas, M. Lobo de Mena, María José Godes Sanz de Bremond, Clara García González, Susana Torres, José Ángel García, Vega Iranzo, Carlos Camps Herrero

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
15

Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer mā Rafael Sirera, Roy M. Bremnes, Andrea Cabrera‐Pastor, Eloísa Jantus‐Lewintre, Elena Sanmartín, Ana Blasco, Nieves del Pozo, Rafael Rosell, Ricardo Guijarro, José M. Galbis, José Javier Sánchez, Carlos Camps

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis mā Harriet E. Gee, Francesca M. Buffa, Carlos Camps, Anassuya Ramachandran, Russell Leek, M Taylor, Meena Patil, Helen Sheldon, Guy Betts, Jarrod J. Homer, Catharine West, Jiannis Ragoussis, Adrian L. Harris

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer mā Sonia Molina‐Pinelo, Ana Salinas, Nicolás Moreno‐Mata, Irene Ferrer, Rocío Suárez, Eduardo Andrés‐León, Manuel Rodríguez‐Paredes, Julian Gutekunst, Eloísa Jantus‐Lewintre, Carlos Camps, Amancio Carnero, Luis Paz‐Ares

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular Profiling mā Eloísa Jantus‐Lewintre, Alessandra Rappa, Dina Ruano, Demi van Egmond, Sandra Gallach, Dilce Gozuyasli, Cecília Durães, José Luís Costa, Carlos Camps, Ludovic Lacroix, Karl Kashofer, Tom van Wezel, Massimo Barberis

I whakaputaina 2025

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer mā R. Rosell, José Gómez‐Codina, Carlos Camps, J Maestre, Jose Padille, Antonio Cantó, José Luís Mate, Shanrong Li, Jorge Roig, Ángel Olazábal, Mercedes Canela, Aurelio Ariza, Z Skácel, Jose Morera-Prat, Albert Abad

I whakaputaina 1994

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers mā Marta Usó, Eloísa Jantus‐Lewintre, Roy M. Bremnes, Silvia Calabuig‐Fariñas, Ana Blasco, Enrique Carbonell Pastor, Irene Borredá, Sonia Molina‐Pinelo, Luis Paz‐Ares, Ricardo Guijarro, Miguel Martorell, Jerónimo Forteza, Carlos Camps, Rafael Sirera

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: